These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32145537)

  • 1. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
    Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
    J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography-Mass Spectrometry.
    Mu Y; Zhou Y; Wang Y; Li W; Zhou L; Lu X; Gao P; Gao M; Zhao Y; Wang Q; Wang Y; Xu G
    J Proteome Res; 2019 May; 18(5):2175-2184. PubMed ID: 30892048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
    Cheng F; Wen Z; Feng X; Wang X; Chen Y
    Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer.
    Chen Y; Ma Z; Shen X; Li L; Zhong J; Min LS; Xu L; Li H; Zhang J; Dai L
    Biomed Res Int; 2018; 2018():5276240. PubMed ID: 30175133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and identification of potential novel lipid biomarkers for non-small cell lung cancer using ultra-high performance liquid chromatography tandem mass spectrometry.
    Han YS; Shi LY; Chen JX; Chen J; Li ZB; Lu QQ; Zhang SQ; Liu J; Yi WJ; Jiang TT; Li JC; Huang J
    Anat Rec (Hoboken); 2022 May; 305(5):1087-1099. PubMed ID: 34347376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary Study on the Biological Markers for I-IIb Stage Non-small Cell Lung Cancer Based on a Serum-peptidomics].
    Hou Y; Guo H; Guo Y; Zhang Y; Han H
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):20-25. PubMed ID: 30674389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.
    Xiang C; Jin S; Zhang J; Chen M; Xia Y; Shu Y; Guo R
    Int J Biol Markers; 2018 Aug; 33(3):314-320. PubMed ID: 29896992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study.
    Ye S; Chen X; Yao Y; Li Y; Sun R; Zeng H; Shu Y; Yin H
    Sci Rep; 2019 Feb; 9(1):2652. PubMed ID: 30804354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood test shows high accuracy in detecting stage I non-small cell lung cancer.
    Goebel C; Louden CL; Mckenna R; Onugha O; Wachtel A; Long T
    BMC Cancer; 2020 Feb; 20(1):137. PubMed ID: 32085733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.
    Wikoff WR; Hanash S; DeFelice B; Miyamoto S; Barnett M; Zhao Y; Goodman G; Feng Z; Gandara D; Fiehn O; Taguchi A
    J Clin Oncol; 2015 Nov; 33(33):3880-6. PubMed ID: 26282655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
    Su K; Zhang T; Wang Y; Hao G
    World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid alterations and subtyping maker discovery of lung cancer based on nontargeted tissue lipidomics using liquid chromatography-mass spectrometry.
    Fan Y; Noreldeen HAA; You L; Liu X; Pan X; Hou Z; Li Q; Li X; Xu G
    J Pharm Biomed Anal; 2020 Oct; 190():113520. PubMed ID: 32784094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.
    Liu WR; Zhang B; Chen C; Li Y; Ye X; Tang DJ; Zhang JC; Ma J; Zhou YL; Fan XJ; Yue DS; Li CG; Zhang H; Ma YC; Huo YS; Zhang ZF; He SY; Wang CL
    Thorac Cancer; 2020 Nov; 11(11):3234-3242. PubMed ID: 32989915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer.
    Du Q; Li E; Liu Y; Xie W; Huang C; Song J; Zhang W; Zheng Y; Wang H; Wang Q
    Cancer Med; 2018 Feb; 7(2):325-335. PubMed ID: 29356357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trial.
    Sun N; Sun S; Gao Y; Li Y; Lu Z; Yuan Z; Che Y; Huang J; Mao S; Lei Y; Zang R; Li N; Cui W; Qi J; Chen F; Gao J; Wang J; Min R; Chen Y; Shi G; Tan F; He J
    Cancer Sci; 2020 May; 111(5):1739-1749. PubMed ID: 32167618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
    Zhang YL; Zhang ZL; Zhu XB; Xu L; Lu P; Xu M; Liu WJ; Zhang XY; Yao HM; Ye XW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.